行情

DXR

DXR

DAXOR CORP
NASDAQ
13.40
-0.23
-1.69%
盘后: 13.12 -0.28 -2.09% 18:13 10/04 EDT
开盘
13.98
昨收
13.63
最高
14.20
最低
13.40
成交量
9,250
成交额
0
52周最高
14.55
52周最低
9.52
市值
5,415.84万
市盈率(TTM)
12.07
分时
5日
1月
3月
1年
5年
暂无数据
DXR 简况
Daxor Corporation is a medical instrumentation and biotechnology company. The Company is focused on blood volume measurement. The Company has developed and marketed the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the food and drug administration (FDA) to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 60,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a broad range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. It has ongoing multicenter trials in the areas of COVID-19 and heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.

微牛提供Daxor Corporation(NASDAQ-DXR)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的DXR股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易DXR股票基本功能。